Communications BiologyBiophysicsPeer-reviewed journal article
A structural and mechanistic model for BSEP dysfunction in PFIC2 cholestatic disease
Abstract
BSEP (ABCB11) transports bile salts across the canalicular membrane of hepatocytes, where they are incorporated into bile. Biallelic mutations in BSEP can cause Progressive Familial Intrahepatic Cholestasis Type 2 (PFIC2), a rare pediatric disease characterized by hepatic bile acid accumulation leading to hepatotoxicity and, ultimately, liver failure. The most frequently occurring PFIC2 disease-causing mutations are missense mutations, which often display a phenotype with decreased protein expression and impaired maturation and trafficking to the canalicular membrane. To characterize the mutational effects on protein thermodynamic stability, we carried out biophysical characterization of 13 distinct PFIC2-associated variants using in-cell thermal shift (CETSA) measurements. These experiments reveal a cluster of residues localized to the NBD2-ICL2 interface, which exhibit severe destabilization relative to wild-type BSEP. A high-resolution (2.8 [A]) cryo-EM structure provides a framework for rationalizing the CETSA results, revealing a novel, NBD2-localized mechanism through which the most severe missense patient mutations drive cholestatic disease.
- organism: human
- assay: structural biology
- research focus: protein folding & dynamics
- approach: biophysical modeling
- Citations
- 6
- FWCI
- 2.45
- Field percentile
- top 10%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Impaired transitioning of the FXR ligand binding domain to an active state underlies an FXR-associated PFIC phenotype
A. Behrendt, A. Bastianelli, … H. Gohlke·bioRxiv·Feb 8, 2024
- Molecular basis of Progressive Familial Intrahepatic Cholestasis 3. A proteomics study.
Laura Guerrero, Lorena Carmona‐Rodríguez, … Fernando José Corrales·BioFactorsPeer-reviewed·Jan 29, 2024
- Protective functions of ZO-2/Tjp2 expressed in hepatocytes and cholangiocytes against liver injury and cholestasis
J. Xu, J. P. Kausalya, … W. Hunziker·bioRxiv·Nov 27, 2019
- Glibenclamide, ATP and Metformin Increases the Expression of Human Bile Salt Export Pump ABCB11
Nisha Vats, Ravi Chandra Dubey, … Senthil Kumar Venugopal·F1000ResearchPeer-reviewed·Dec 22, 2020
- Periductal bile acid exposure causes cholangiocyte injury and fibrosis
M. Dotan, S. Fried, … O. Waisbourd-Zinman·bioRxiv·Feb 16, 2022
- A physiology-based model of bile acid metabolism shows altered tissue concentrations after drug administration and in specific genotype subgroups
Vanessa Baier, H. Cordes, … Lars Kuepfer·bioRxiv·Oct 24, 2018